Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177473 · ClinicalTrials.gov registry record
Study Using the CervicalStim Device Following Cervical Fusion
A clinical trial, sponsored by Orthofix.
- Completed
- Registry status
- 211
- Enrollment target
NCT03177473: Completed study, sponsored by Orthofix.
NCT03177473 is a clinical trial that has completed, run by Orthofix. The registered enrollment target is 211 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177473 has completed, sponsored by Orthofix.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
This study examines the effect of adjunctive use of the CervicalStim bone growth stimulator on cervical fusion rate in high risk subjects who have undergone cervical fusion surgery. All participants will wear the bone growth stimulator every day for 4 hours/day for 6 months.
Primary Outcome
fusion rate assessed via radiographic confirmation (Xray and CT)
Interventions
- DEVICE CervicalStim bone growth stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2021-08-03 |
What the finished NCT03177473 record still lists
NCT03177473 is an observational study that tracks outcomes without assigning an intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CervicalStim bone growth stimulator is the first listed.
NCT03177473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03177473 about?
NCT03177473 is a clinical study titled "Study Using the CervicalStim Device Following Cervical Fusion". This study examines the effect of adjunctive use of the CervicalStim bone growth stimulator on cervical fusion rate in high risk subjects who have undergone cervical fusion surgery. All participants will wear the bone growth stimulator every day for 4 hours/day for 6 months.
What is the current status of trial NCT03177473?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2017-06-28. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT03177473?
The interventions under investigation include: CervicalStim bone growth stimulator (DEVICE).
Who is sponsoring clinical trial NCT03177473?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI